An immune checkpoint molecule, SA-4-1BB developed for cancer immunotherapy also protects against future development of multiple types of cancer when administered by itself, shows a new study.
The recombinant protein molecule SA-4-1BBL has been used to enhance the therapeutic efficacy of cancer vaccines with success in pre-clinical animal models.
Firstly, it greatly depends on how you define immortality. If you define it as living forever and being indestructible as in a comic book, then, no, it is highly unlikely. However, if you define it in terms of showing no decline in survival characteristics, no increase in disease incidence and no increase in mortality with advancing age, then yes. The first is a science-fiction fantasy; the second is based on real-world biology that evolution has already selected for in certain species. We call this state negligible senescence.
Senescence and negligible senescence
Researchers have developed a next-generation bionic hand that allows amputees to regain their proprioception. The results of the study, which have been published in Science Robotics, are the culmination of ten years of robotics research.
The next-generation bionic hand, developed by researchers from EPFL, the Sant’Anna School of Advanced Studies in Pisa and the A. Gemelli University Polyclinic in Rome, enables amputees to regain a very subtle, close-to-natural sense of touch. The scientists managed to reproduce the feeling of proprioception, which is our brain’s capacity to instantly and accurately sense the position of our limbs during and after movement – even in the dark or with our eyes closed.
The new device allows patients to reach out for an object on a table and to ascertain an item’s consistency, shape, position and size without having to look at it. The prosthesis has been successfully tested on several patients and works by stimulating the nerves in the amputee’s stump. The nerves can then provide sensory feedback to the patients in real time – almost like they do in a natural hand.
Researchers at Tel Aviv University say they have developed a new, noninvasive method of discovering genetic disorders that can let parents find out the health of their fetus as early as 11 weeks into pregnancy.
A simple blood test lets doctors diagnose genetic disorders in fetuses early in pregnancy by sequencing small amounts of DNA in the mother’s and the father’s blood. A computer algorithm developed by the researchers analyzes the results of the sequencing and then produces a “map” of the fetal genome, predicting mutations with 99 percent or better accuracy, depending on the mutation type, the researchers said in a study published Wednesday in Genome Research.
The algorithm is able to distinguish between the genetic material of the parents and that of the fetus, said Prof. Noam Shomron of Tel Aviv University’s Sackler School of Medicine led the research, in a phone interview with The Times of Israel.
Continue reading “Israeli team develops way to find genetic flaws in fetus at 11 weeks” »
Proton pump inhibitors (PPIs), which include well-known brand names Prilosec, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease. Given their prevalence, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego mined the FDA Adverse Effect Reporting System (FAERS) database for unexpected consequences of PPI consumption.
In the study, published February 19, 2019 by Scientific Reports, the team found that patients who took PPIs were more likely to experience kidney disease than people who took histamine-2 receptor antagonists, another form of antacid that treats the same conditions and includes the brands Pepcid and Zantac.
“Post-marketing data collected by the FDA and deposited in the FAERS database allows us to look for potential adverse effects beyond what was found in a clinical trial, which may not have lasted as long or included as much diversity as the FAERS does,” said senior author Ruben Abagyan, Ph.D., professor of pharmacy.
Continue reading “Common acid reflux medications linked to increased kidney disease risk” »
A new study published in the journal Molecular Psychiatry is suggesting high iron levels in the brain may fundamentally trigger the progressive neurodegeneration associated with dementia and Alzheimer’s disease. A clinical trial is now underway exploring whether Alzheimer’s-related cognitive decline can be slowed by lowering brain iron levels.
(CNN) — The risk of having a heart attack appears to be rising among young women, according to a new study, and researchers are trying to figure out why.
When analyzed across five-year intervals, the overall proportion of heart attack-related hospital admissions in the United States attributable to young patients, ages 35 to 54, steadily climbed from 27% in 1995–99 to 32% in 2010–14, with the largest increase observed in young women, according to the study, published recently in the journal Circulation.
During those periods, there was a rise in these admissions from 21% to 31% among young women, compared with 30% to 33% among young men, the study showed.
Continue reading “Heart attacks rising among young women, study shows” »
